Sonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Glofitamab
Related studies linked through entity extraction aliases.
Glofitamab in B-NHL Using Mid-Therapy Intratumoral Transcriptomics
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
AI-Driven Treatment Strategy vs ZR2 in Older Treatment-naive Patients With LBCL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
GLORY: Glofit-GemOx With Liso-Cel For Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real-World Study of Bispecific Antibody in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
External Beam Radiotherapy Followed by Bispecific Antibody Therapy for Relapsed/Refractory DLBCL
- Status
- RECRUITING
- Phase
- PHASE1
Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Glofitamab in Real Life
- Status
- RECRUITING
- Phase
- N/A
Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma
- Status
- SUSPENDED
- Phase
- PHASE1
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1